• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report.采用基于初级保健和药房的模式提供注射用阿片类激动剂治疗重度阿片类物质使用障碍：一例报告。
CMAJ. 2020 Feb 3;192(5):E115-E117. doi: 10.1503/cmaj.190732.
2
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.用于阿片类物质使用障碍的注射用阿片类激动剂治疗：一项国家临床指南。
CMAJ. 2019 Sep 23;191(38):E1049-E1056. doi: 10.1503/cmaj.190344.
3
Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans.加拿大注射用阿片类激动剂治疗的服务提供模式：2 项连续的环境扫描。
CMAJ Open. 2021 Feb 23;9(1):E115-E124. doi: 10.9778/cmajo.20200021. Print 2021 Jan-Mar.
4
Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency.氢吗啡酮与二乙酰吗啡在长期阿片类药物依赖替代治疗中的效价比。
J Opioid Manag. 2011 Sep-Oct;7(5):371-6. doi: 10.5055/jom.2011.0078.
5
Initiation of injectable opioid agonist treatment in hospital: A case report.在医院启动注射用阿片类激动剂治疗：病例报告。
Drug Alcohol Rev. 2020 Feb;39(2):138-141. doi: 10.1111/dar.13020. Epub 2019 Dec 9.
6
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.限时静脉注射氢吗啡酮治疗治疗抵抗性注射阿片类药物使用障碍患者的实施：一项评估可行性、安全性和成本的单中心、非对照、开放标签研究方案。
BMJ Open. 2024 Aug 3;14(8):e082553. doi: 10.1136/bmjopen-2023-082553.
7
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.注射用氢吗啡酮和二乙酰吗啡用于长期重度阿片类药物使用障碍的安全性概况。
Drug Alcohol Depend. 2017 Jul 1;176:55-62. doi: 10.1016/j.drugalcdep.2017.02.021. Epub 2017 May 10.
8
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder.在支持性住房环境中进行的监督下注射用阿片类激动剂治疗，用于治疗重度阿片类药物使用障碍。
BMJ Case Rep. 2019 Aug 1;12(7):e229456. doi: 10.1136/bcr-2019-229456.
9
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.COVID-19大流行期间及之后用于阿片类物质使用障碍的居家注射用阿片类药物亟待解决：一项案例研究
Subst Abuse Treat Prev Policy. 2021 Mar 5;16(1):22. doi: 10.1186/s13011-021-00358-x.
10
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods.注射用氢吗啡酮治疗：双盲和开放标签治疗期的保留率比较。
J Subst Abuse Treat. 2019 Jun;101:50-54. doi: 10.1016/j.jsat.2019.03.012. Epub 2019 Apr 4.

引用本文的文献

1
A cross-sectional study of factors associated with unstable housing among marginalized people who use drugs in Ottawa, Canada.加拿大渥太华边缘化吸毒人群中与不稳定住房相关因素的横断面研究。
PLoS One. 2021 Jul 1;16(7):e0253923. doi: 10.1371/journal.pone.0253923. eCollection 2021.
2
Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada.在加拿大渥太华，边缘化的吸毒人群参与基层医疗保健。
BMC Health Serv Res. 2020 Sep 7;20(1):837. doi: 10.1186/s12913-020-05670-z.

本文引用的文献

1
Management of opioid use disorders: a national clinical practice guideline.阿片类物质使用障碍的管理：一项国家临床实践指南。
CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958.
2
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.氢吗啡酮与二乙酰吗啡治疗长期阿片类药物依赖的随机临床试验。
JAMA Psychiatry. 2016 May 1;73(5):447-55. doi: 10.1001/jamapsychiatry.2016.0109.
3
Heroin maintenance for chronic heroin-dependent individuals.为慢性海洛因依赖者提供海洛因维持治疗。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003410. doi: 10.1002/14651858.CD003410.pub4.
4
Diacetylmorphine versus methadone for the treatment of opioid addiction.二乙酰吗啡与美沙酮治疗阿片类成瘾的比较
N Engl J Med. 2009 Aug 20;361(8):777-86. doi: 10.1056/NEJMoa0810635.

Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report.

作者信息

Wilson Tyler, Brar Rupi, Sutherland Christy, Nolan Seonaid

机构信息

British Columbia Centre on Substance Use (Wilson, Brar, Sutherland, Nolan); Department of Medicine (Brar, Nolan, Sutherland), University of British Columbia, St. Paul's Hospital, Vancouver, BC.

British Columbia Centre on Substance Use (Wilson, Brar, Sutherland, Nolan); Department of Medicine (Brar, Nolan, Sutherland), University of British Columbia, St. Paul's Hospital, Vancouver, BC

出版信息

CMAJ. 2020 Feb 3;192(5):E115-E117. doi: 10.1503/cmaj.190732.

DOI:10.1503/cmaj.190732
PMID:32015080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7004215/
Abstract
摘要